Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutics of Neurotransmitters in Alzheimer’s Disease
Ramesh Kandimalla, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1049-1069
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment
Shan Liu, Jiguo Gao, Mingqin Zhu, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5026-5043
Open Access | Times Cited: 326
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Martí Colom‐Cadena, Tara L. Spires‐Jones, Henrik Zetterberg, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 245
A Perspective on Multi-target Drugs for Alzheimer’s Disease
Ondřej Benek, Jan Korábečný, Ondřej Soukup
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 434-445
Closed Access | Times Cited: 204
Revisiting the role of neurotransmitters in epilepsy: An updated review
Enes Akyüz, Ayse Kristina Polat, Ece Eroğlu, et al.
Life Sciences (2020) Vol. 265, pp. 118826-118826
Closed Access | Times Cited: 191
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Salman Ul Islam, Adeeb Shehzad, Muhammad Bilal Ahmed, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1929-1929
Open Access | Times Cited: 146
Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer’s disease
Julie C. Lauterborn, Pietro Scaduto, Conor D. Cox, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis
Hui-Ling Wei, Chunyang Yu, Chun Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114308-114308
Open Access | Times Cited: 90
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 65
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Zhenqi Yang, Yong Zou, Lifeng Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3841-3841
Open Access | Times Cited: 47
A review: Progress and trend advantage of dopamine electrochemical sensor
Abdul Karim, M. Yasser, Ahyar Ahmad, et al.
Journal of Electroanalytical Chemistry (2024) Vol. 959, pp. 118157-118157
Closed Access | Times Cited: 21
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
Chengxuan Chen, Zhao Zhang, Yuan Liu, et al.
Science Advances (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Exploration of natural products for the development of promising Cholinesterase inhibitors in Alzheimer’s disease treatment
Hassan Nour, Oussama Abchır, Nouh Mounadi, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42479-e42479
Open Access | Times Cited: 2
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
Luke Whiley, Katie E. Chappell, Ellie D’Hondt, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 89
Therapeutic nanoplatforms and delivery strategies for neurological disorders
You Jung Kang, Eric Gerard Cutler, Hansang Cho
Nano Convergence (2018) Vol. 5, Iss. 1
Open Access | Times Cited: 87
Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay
Aimi Syamima Abdul Manap, Amelia Cheng Wei Tan, Weng Hhin Leong, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 87
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition
Alexander G. Murley, Matthew A Rouse, P. Simon Jones, et al.
Brain (2020) Vol. 143, Iss. 11, pp. 3449-3462
Open Access | Times Cited: 80
Mitochondrial dysfunction, mitophagy, and role of dynamin‐related protein 1 in Alzheimer's disease
Vijay Krishna Medala, Buchaiah Gollapelli, Saikat Dewanjee, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 4, pp. 1120-1135
Closed Access | Times Cited: 58
BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
Firas H. Bazzari, Amjad H. Bazzari
Molecules (2022) Vol. 27, Iss. 24, pp. 8823-8823
Open Access | Times Cited: 48
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 45
Advances in polysaccharides of natural source of the anti-Alzheimer's disease effect and mechanism
Zhiyuan Zhang, Shuai Wang, Haining Tan, et al.
Carbohydrate Polymers (2022) Vol. 296, pp. 119961-119961
Closed Access | Times Cited: 43
Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease
Gianluca Antonio Franco, Livia Interdonato, Marika Cordaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7318-7318
Open Access | Times Cited: 36
Advanced near‐infrared light approaches for neuroimaging and neuromodulation
Hongqiang Yin, Wuqiao Jiang, Yongyang Liu, et al.
BMEMat (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 33
Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
Lingyan Zheng, Sichen Wu, Haichao Jin, et al.
Phytomedicine (2023) Vol. 116, pp. 154890-154890
Closed Access | Times Cited: 22
Neuropharmacological insights into Gardenia jasminoides Ellis: Harnessing therapeutic potential for central nervous system disorders
Ziyu Hou, Le Sun, Zheyu Jiang, et al.
Phytomedicine (2024) Vol. 125, pp. 155374-155374
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top